No End to the Crisis without an End to the Waiver

Ahmad F , Rossen L , Spencer M , Warner M , Sutton P . Provisional drug overdose death counts. National Center for Health Statistics. 2018. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm?wpisrc=nl_health202&wpmm=1. Accessed August 9, 2018.

Sordo L , Barrio G , Bravo MJ . Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550

Oliva EM , Trafton JA , Harris AH , Gordon AJ . Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand? Am J Drug Alcohol Abuse. 2013;39(2):103–107.

Wyse JJ , Gordon AJ , Dobscha SK , . Medications for opioid use disorder in the Department of Veterans Affairs (VA) Health Care System: historical perspective, lessons learned and next steps. Subst Abus. 2018 Mar 29. [Epub ahead of print]. doi: 10.1080/08897077.2018.1452327

Oliva EM , Maisel NC , Gordon AJ , Harris AH . Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep. 2011;13:374–381.

Courtwright DT . Preventing and treating narcotic addiction-century of federal drug control. N Engl J Med. 2015;373:2095–2097.

Jin Fuey Moy v. United States, 254 U.S. 189 (1920). https://www.law.cornell.edu/supremecourt/text/254/189. Accessed October 22, 2018.

Narcotic Addict Treatment Act of 1974. Public Law No. 93–281. https://www.gpo.gov/fdsys/pkg/STATUTE-88/pdf/STATUTE-88-Pg124.pdf. Accessed August 9, 2018.

Drug Addiction Treatment Act of 2000. Public Law No. 106–310, Title XXXV. https://www.congress.gov/106/plaws/publ310/PLAW-106publ310.pdf. Accessed August 9, 2018.

Comprehensive Addiction and Recovery Act of 2016. Public Law No. 114–198. https://www.congress.gov/114/plaws/publ198/PLAW-114publ198.pdf. Accessed August 9, 2018.

Tierney M , Finnell DS , Naegle MA , LaBelle C , Gordon AJ . Advanced practice nurses: Increasing access to opioid treatment by expanding the pool of qualified buprenorphine prescribers. Subst Abus. 2015;36:389–392.

Physician and Program Data. https://www.samhsa.gov/programs-campaigns/medication-assisted-treatment/training-materials-resources/physician-program-data. Accessed October 22, 2018.

Wu LT , Zhu H , Swartz MS . Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117–127.

Valenstein-Mah H , Hagedorn H , Kay CL , Christopher ML , Gordon AJ . Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration. Subst Abus. 2018 Oct 16 [Epub ahead of print]. doi: 10.1080/08897077.2018.1509251.

Stein BD , Sorbero M , Dick AW , . Physician capacity to treat opioid use disorder with Buprenorphine-Assisted treatment. JAMA 2016;316:1211–1212.

Jones CM , Campopiano M , Baldwin G , McCance-Katz E . National and state treatment need and capacity for opioid agonist Medication-Assisted treatment. Am J Public Health. 2015;105:e55–e63.

Gordon AJ , Liberto J , Granda S , . Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration. Am J Addict. 2008;17:459–462.

Gordon AJ , Liberto J , Granda S , . Physician training is never a failure. Am J Addict. 2009;18:337–338.

Wakeman SE , Barnett ML . Primary care and the Opioid-Overdose Crisis-Buprenorphine myths and realities. N Engl J Med. 2018;379:1–4.

Fatseas M , Dubernet J , Daoulouede J-P , Auriacombe M . Buprenorphine in the Treatment of Opioid Addiction: The French Experience. In: el-Guebaly N , Carra N , Galanter M , eds. Textbook of Addiction Treatment: International Perspectives. Vol 1. New York, NY: Springer; 2015.

Schuman-Olivier Z , Albanese M , Nelson SE , . Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers. J Subst Abuse Treat. 2010;39:41–50.